Valuation: Integrated Diagnostics Holdings plc

Market Cap 15B 267M 240M 222M 201M 375M 25.47B 380M 2.65B 1.06B 13.33B 1B 982M 42.31B P/E 2026 *
-
P/E 2027 * 6.62x
Enterprise Value 14B 250M 224M 207M 188M 350M 23.78B 355M 2.48B 986M 12.44B 937M 917M 39.5B EV / Sales 2026 *
1.3x
EV / Sales 2027 * 1.02x
Free-Float
38.59%
Yield 2026 *
3.2%
Yield 2027 * 4.96%
1 day-4.17%
1 week-6.12%
Current month-16.06%
1 month-11.54%
3 months-14.81%
6 months-23.33%
Current year-38.26%
1 week 0.46
Extreme 0.46
0.51
1 month 0.46
Extreme 0.46
0.55
Current year 0.46
Extreme 0.46
0.84
1 year 0.46
Extreme 0.46
0.84
3 years 0.28
Extreme 0.275
0.84
5 years 0.28
Extreme 0.275
1.45
10 years 0.28
Extreme 0.275
1.45
Manager TitleAgeSince
Chief Executive Officer 57 23/12/2014
Director of Finance/CFO 62 18/01/2024
Investor Relations Contact - 01/12/2023
Director TitleAgeSince
Director/Board Member 57 01/01/2012
Director/Board Member 75 12/01/2015
Director/Board Member 61 12/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
15/10/26 Buy

Chief Executive Officer

15,580,812 2.6802%
17/10/23 Buy

Chief Executive Officer

1,058,730 0.1765%
16/10/23 Buy

Chief Executive Officer

826,500 0.1378%
Change 5-day change 1-year change 3-year change Capi.($)
-4.17%-6.12%-19.30%+21.05% 279M
-1.29%-5.07%+9.10%+35.69% 117B
+2.95%-0.54%-0.99%+105.61% 97.42B
+3.31%+4.56%+120.80%+1,009.30% 59.22B
+0.23%+2.97%-6.19%+89.51% 29.03B
+8.78%+11.49%+30.69%+81.07% 26.86B
+1.26%+3.58%+36.26%+92.37% 26.69B
+2.46%-1.40%+24.21%+405.46% 21.1B
+0.95%+2.20%-16.82%-0.93% 20.61B
-0.13%-1.01%-6.23%+31.16% 16.94B
Average +1.36%-0.44%+17.15%+187.03% 41.47B
Weighted average by Cap. +1.61%-1.40%+23.59%+218.30%

Financials

2026 *2027 *
Net sales 10.76B 192M 172M 159M 144M 269M 18.26B 272M 1.9B 758M 9.56B 720M 704M 30.34B 12.36B 220M 198M 183M 166M 309M 20.99B 313M 2.19B 871M 10.99B 827M 810M 34.88B
Net income 1.94B 34.61M 31.05M 28.71M 26M 48.57M 3.3B 49.16M 343M 137M 1.72B 130M 127M 5.48B 2.26B 40.37M 36.22M 33.49M 30.33M 56.67M 3.85B 57.35M 400M 159M 2.01B 152M 148M 6.39B
Net Debt -996M -17.75M -15.93M -14.73M -13.34M -24.92M -1.69B -25.22M -176M -70.13M -885M -66.62M -65.22M -2.81B -2.35B -41.88M -37.58M -34.74M -31.46M -58.78M -3.99B -59.49M -415M -165M -2.09B -157M -154M -6.63B
Projected Income Statement - Annual - Integrated Diagnostics Holdings plc
Logo Integrated Diagnostics Holdings plc
Integrated Diagnostics Holdings PLC is a diagnostics services provider. The Company operates in the Middle East and Africa with operations in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Company is engaged in offering services in immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, histopathology, genetics, radiology, and others. The Company’s brands include Al Borg, Al Borg Scan, Al Mokhtabar, Biolab, Echo-Lab, Ultralab, Al Mokhtabar Sudan and Biolab KSA. It operates through approximately 628 branches. It offers more than 3,000 diagnostics tests ranging from routine to advanced. Its common tests include those for cholesterol, diabetes, pregnancy, and substance abuse. Through Al Borg Scan, it offers a full range of radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), electromyography, electrocardiogram (ECG), electroencephalogram (EEG), ultrasound, x-ray, mammograms and cath lab facilities, others.
Employees
7,137
Date Price Change Volume
28/10/26 $0.4600 -4.17% 82,377
27/10/26 $0.4800 0.00% 70,258
26/10/26 $0.4800 -2.04% 14,195
23/10/26 $0.4900 0.00% 2,671
22/10/26 $0.4900 -2.00% 1,413
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Integrated Diagnostics Holdings plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
26.93EGP
Average target price
44.56EGP
Spread / Average Target
+65.46%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Integrated Diagnostics Holdings plc
  1. Stock Market
  2. Stocks
  3. IDHC Stock